Inhibitor development and mortality in non-severe hemophilia A-Reference-Cited by-同舟云学术

Inhibitor development and mortality in non-severe hemophilia A

Published:2015-06-10 Issue:7 Volume:13 Page:1217-1225
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Eckhardt C. L.¹,Loomans J. I.¹,van Velzen A. S.¹,Peters M.¹,Mauser-Bunschoten E. P.²,Schwaab R.³,Mazzucconi M. G.⁴,Tagliaferri A.⁵,Siegmund B.⁶,Reitter-Pfoertner S. E.⁷,van der Bom J. G.⁸⁹¹⁰,Fijnvandraat K.¹,

Affiliation:

1. Department of Pediatric Hematology; Emma Children's Hospital; Academic Medical Center; Amsterdam the Netherlands

2. Department of Hematology; van Creveldkliniek; University Medical Center Utrecht; Utrecht the Netherlands

3. Institute of Experimental Haematology and Transfusion Medicine; University Clinic Bonn; Bonn Germany

4. Department of Cellular Biotechnology and Hematology; Sapienza University of Rome; Rome Italy

5. Regional Reference Centre for Inherited Bleeding Disorders; University Hospital; Parma Italy

6. Institute for Thrombophilia and Haemostaseology; Raphaelsklinik; Munster Germany

7. Clinical Division of Haematology and Haemostaseology; Department of Medicine I; Medical University of Vienna; Vienna Austria

8. Center for Clinical Transfusion Research; Sanquin Research; Leiden the Netherlands

9. Jon J. van Rood Center for Clinical Transfusion Research; Leiden University Medical Center; Leiden the Netherlands

10. Department of Clinical Epidemiology; Leiden University Medical Center; Leiden the Netherlands

Funder

The Netherlands Organisation for Health Research and Development

(ZonMW)

CSL Behring

Novo Nordisk

Baxter Bioscience

Stichting

Stichting (foundation) Steun Emma

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12990/fullpdf

Reference26 articles.

1. Diagnosis and management of haemophilia;Fijnvandraat;BMJ,2012

2. Hemophilia A in the third millennium;Franchini;Blood Rev,2013

3. Desmopressin for the treatment of haemophilia;Castaman;Haemophilia,2008

4. Literature review of surgery management in inhibitor patients;Rodriguez-Merchan;Haemophilia,2004

5. Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A;Eckhardt;Blood,2013

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nonsevere Hemophilia: The Need for a Renewed Focus and Improved Outcomes;Seminars in Thrombosis and Hemostasis;2024-05-11

2. Expert Opinions on the Management of Hemophilia A in India: The Role of Emicizumab;Cureus;2024-04-24

3. Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers;Frontiers in Oncology;2024-04-19

4. The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A;Frontiers in Immunology;2024-02-22

5. Peri‐operative desmopressin combined with pharmacokinetic‐guided factor VIII concentrate in non‐severe haemophilia A patients;Haemophilia;2024-02-11